GRPR and familial pancreatic carcinoma: On the other hand, bombesin (BBN) derivatives have the ability to recognize the gastrin-releasing peptide receptor (GRPR) that is overexpressed in several human tumors such as breast, prostate, and pancreatic cancer [14].